Current Opinion in Hematology

Papers
(The median citation count of Current Opinion in Hematology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Translational control by heme-regulated elF2α kinase during erythropoiesis55
Proteome remodeling and organelle clearance in mammalian terminal erythropoiesis38
Unrelated hematopoietic stem cell donor registries: present reality and future prospects35
Viral infection after hematopoietic stem cell transplantation34
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation21
Control of inflammatory lung injury and repair by metabolic signaling in endothelial cells20
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies19
Editorial introductions17
Symmetric and asymmetric activation of hematopoietic stem cells15
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis14
The significance of CUX1 and chromosome 7 in myeloid malignancies13
Editorial introductions12
Is it the time to integrate novel sequencing technologies into clinical practice?12
Editorial: the new age of clinical research in clonal hematopoiesis and myeloid malignancies12
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential12
Macrocytic anemias11
Shedding light on GPIbα shedding11
Clinical experience of coronavirus disease 2019 in hematopoietic cell transplant and chimeric antigen receptor T-cell recipients11
In-vivo functions and regulation of polyphosphate in the vascular system11
Editorial introductions11
Global perspectives on cellular therapy for children with sickle cell disease11
Lipid mediators in neutrophil biology: inflammation, resolution and beyond10
Vascular microphysiological systems10
Editorial introductions10
Editorial introduction10
Local and systemic features of ILC immunometabolism9
Editorial introduction9
Red cell extracellular vesicles and coagulation activation pathways9
Hormetic endoplasmic reticulum stress in hematopoietic stem cells9
Editorial introductions9
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia9
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis8
Mouse models of vascular development and disease8
Desialylation by neuraminidases in platelets, kiss of death or bittersweet?8
Chimeric antigen receptor T-cell therapy in acute myeloid leukemia8
Targeting the cluster of differentiation 47/signal-regulatory protein alpha axis in myeloid malignancies8
Mixed donor chimerism following stem cell transplantation for sickle cell disease7
Erythroid cells and malaria parasites: it's a match!7
Signaling networks guiding erythropoiesis7
Diverse functions of long noncoding RNAs in acute myeloid leukemia: emerging roles in pathophysiology, prognosis, and treatment resistance7
Age-related micro-environmental changes as drivers of clonal hematopoiesis7
Hematopoietic stem cell collection for sickle cell disease gene therapy7
Thrombosis in myeloproliferative neoplasms: update in pathophysiology6
Secondary stroke prevention in patients with patent foramen ovale6
Understanding and targeting erythroid progenitor cells for effective cancer therapy6
Editorial introductions6
The impact of prenatal inflammation on hematopoietic development6
The protein C pathways6
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis6
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective6
Methods to quantify endothelial cell front-rear polarity in vivo and in vitro6
Editorial Introductions6
Deficits in our understanding of natural killer cell development in mouse and human6
Novel neutrophil biology insights underlying atypical chemokine receptor-1/Duffy antigen receptor of chemokines-associated neutropenia6
Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding5
Single-cell RNA sequencing to study vascular diversity and function5
Brothers in arms: platelets and neutrophils in ischemic stroke5
Histological differences among thrombi in thrombotic diseases5
Editorial introduction5
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implicati4
Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication4
Modeling genetic platelet disorders with human pluripotent stem cells: mega-progress but wanting more on our plate(let)4
Editorial: New technological developments and their impact in vascular research4
Translation defects in ribosomopathies4
Meningeal Lymphatic vasculature in health and disease3
Transcription factor regulation of ribosomal RNA in hematopoiesis3
Platelet lipidomics and de novo lipogenesis: impact on health and disease3
The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease3
Regulation and importance of factor VIII levels in hemophilia A carriers3
‘Enhancing’ red cell fate through epigenetic mechanisms3
The role of hematopoiesis in bone repair: an update3
Protease activated receptor-4: ready to be part of the antithrombosis spectrum3
Inflammation and bone marrow fibrosis: novel immunotherapeutic targets3
Modelling arterial thrombus formation in vitro3
Current Opinion in Hematology3
Transfusion avoidance in myelodysplastic neoplasms3
Alteration of interleukin-10-producing Type 1 regulatory cells in autoimmune diseases3
Editorial introductions3
The immunology of PF4 polyanion interactions3
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms2
Pediatric acute myeloid leukemia – novel approaches2
Detecting and preventing post-hematopoietic cell transplant relapse in AML2
Venous thromboembolism: diagnostic advances and unaddressed challenges in management2
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology2
Chediak-Higashi syndrome2
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods2
Histon activities in the extracellular environment: regulation and prothrombotic implications2
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromes2
Warm autoimmune hemolytic anemia: new insights and hypotheses2
Platelet-derived extracellular vesicles in cardiovascular disease and treatment – from maintaining homeostasis to targeted drug delivery2
Emerging therapeutic and preventive approaches to transplant-associated thrombotic microangiopathy2
Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease2
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function2
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance2
Mechanisms of immunothrombosis in COVID-192
N6-methyladenosine in hematological malignancies: a concise review2
Update on preclinical and clinical efforts on ex-vivo expansion of hematopoietic stem and progenitor cells2
Iron status of blood donors2
Developmental regulation of primitive erythropoiesis1
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease1
Improving our understanding on the clinical role of plasmin-mediated von Willebrand factor degradation1
Ineffective erythropoiesis in sickle cell disease: new insights and future implications1
Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters1
Editorial introductions1
Hidden behind thromboinflammation: revealing the roles of von Willebrand factor in sickle cell disease pathophysiology1
Circulating endothelial cells in pathophysiology1
Editorial introduction1
Editorial: Current Opinion in Hematology: new editor announcement1
Disparities in acute myeloid leukemia treatments and outcomes1
Fibrin structure, viscoelasticity and lysis face the interplay of biorelevant polyions1
Immunologic effects of red blood cell and platelet transfusions in neonates1
Crosstalk between terminal erythropoiesis and granulopoiesis within their common niche: the erythromyeloblastic island1
Recent lessons learned for ex-vivo platelet production1
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation1
Role of chimeric antigen receptor T-cell therapy: bridge to transplantation or stand-alone therapy in pediatric acute lymphoblastic leukemia1
Immunomodulatory roles of red blood cells1
Emerging functional microfluidic assays for the study of thromboinflammation in sickle cell disease1
Platelet mechanosensing as key to understanding platelet function1
Platelet mitochondria: the mighty few1
Red blood cell changes due to cancer and cancer treatments: a narrative review1
The fulfilled promise and unmet potential of umbilical cord blood1
New insights of glycoprotein Ib-IX-V complex organization and glycoprotein Ibα in platelet biogenesis1
0.03133487701416